Update in treatment of Symptomatic newly Diagnosed Transplant Eligible Multiple Myeloma Patients

Nahla A M Hamed
Additional contact information
Nahla A M Hamed: Professor of Clinical Hematology, Hematology Department, Faculty of Medicine, Alexandria University, Egypt

Cancer Therapy & Oncology International Journal, 2020, vol. 15, issue 3, 96-99

Abstract: The updated criteria for multiple myeloma (MM) diagnosis requires evidence of either 10% or more clonal plasma cells in bone marrow examination or a biopsy-proven plasmacytoma in addition to the presence of one or more myeloma defining events (MDE). MDE consists of established CRAB features (hypercalcemia, renal failure, anemia, or lytic bone lesions) as well as 3 specific biomarkers: clonal bone marrow plasma cells ≥60%, serum free light chain (FLC) ratio ≥100 (provided involved FLC level is ≥100 mg/L), and more than one focal lesion on MRI [1].

Keywords: juniper publishers:oncology journals; oncology research journals; oncology journal articles; oncology and cancer case reports; oncology journal of clinical and experimental cancer research; open access; open access journals; Oncology International Journal; juniper publishers reivew (search for similar items in EconPapers)
Date: 2020
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/ctoij/pdf/CTOIJ.MS.ID.555913.pdf (application/pdf)
https://juniperpublishers.com/ctoij/CTOIJ.MS.ID.555913.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jctoij:v:15:y:2020:i:3:p:96-99

DOI: 10.19080/CTOIJ.2020.15.555913

Access Statistics for this article

Cancer Therapy & Oncology International Journal is currently edited by Sophia Mathis

More articles in Cancer Therapy & Oncology International Journal from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().